ACUVUE Oasys MAX 1-Day MULTIFOCAL (30) 1 confezione di 30 lenti - Lenti giornaliere - Johnson & Johnson

Image-Product-0 Image-Product-1
prodotto per la manutenzione ACUVUE Oasys MAX 1-Day MULTIFOCAL (30) Nuovo

1. prodotto

30  lenti  43,90 

2. Parametri

Occhio destro
8,40
14,30
Scatole per occhio
Occhio sinistro
8,40
14,30
Scatole per occhio
È stata scelta una correzione (+) per un occhio e (-) per l'altro occhio.
Volete confermare?

3. Spedizione

Inserire i parametri per visualizzare la data di consegna.
CE
Questo prodotto é marcato CE ed é conforme ai requisiti della normativa europea
1. JJV Data on File. CSM Subjective Responses ACUVUE® OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis. 2. JJV Data on File 2022. TearStable Technology Definition. Evaluation du taux de pervaporation parmi les 6 lentilles de contact ACUVUE® OASYS MAX 1-Day, ACUVUE® OASYS 1-Day, DAILIES TOTAL1®, ULTRA® One Day, Precision 1® et MyDay®. Evaluation du pourcentage moyen du filtre de lumière bleu-violet parmi les 6 lentilles de contact ACUVUE® OASYS MAX 1-Day, ACUVUE® OASYS 1-Day, DAILIES TOTAL1®, ULTRA® One Day, Precision 1® et MyDay®. 3. JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artefacts of ACUVUE® OASYS MAX 1-Day Family with TearStable Technology. Étude monocentrique, randomisée, contrôlée, basée sur une seule visite, en double aveugle, n=58 patients. Critères primaires : diffusion lumineuse, halos, stries lumineuses. 4. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxeTM Technology and ACUVUE® OASYS MAX 1-Day with TearStable Technology Brand Contact Lenses and other daily disposable contact lens brands. 5. JJV Data on File 2022. Subjective Stand-Alone Claims for ACUVUE OASYS MAX 1-Day MULTIFOCAL Contact Lenses - Exploratory Meta-analysis. 6. Protocole d’adaptation proposé par le laboratoire. Sous réserve du respect de l’Arrêté du 25 octobre 2016 fixant la liste des situations médicales prévues aux articles D. 4362-11-1 et D. 4362-12-1 du code de la santé publique. 7. McCabe KP, Molock FF, Hill GA, et al, inventors; Johnson & Johnson Vision Care, Inc., Jacksonville, FL (US), assignee. BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS, Table 11. United States patent US 6,822,016 B2. patent application 10/236,538. Nov. 23,2004.).